Home / CHF / BioVentrix Announces Appointment of Accredited Public Company Director Raymond W. Cohen to its Board of Directors

BioVentrix Announces Appointment of Accredited Public Company Director Raymond W. Cohen to its Board of Directors

BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure via Transcatheter Ventricular Restoration (TCVR), today announced the appointment of Raymond W.
Read Full Story at source (may require registration)